Ken Griffin (Citadel Advisors) exit Vertex Pharmaceuticals Inc
Ken Griffin (Citadel Advisors) exit $-358.1M of disclosed value in Vertex Pharmaceuticals Inc.
Signal
Investor Move
Action
Exit
Capital
$-358.1M disclosed value
Why it matters
This action comes from parsed SEC 13F holdings and highlights where tracked institutional capital changed materially versus the previous comparable filing period.